Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans

Vascular Health and Risk Management

Volumn 3, Issue 5, 2007, Pages 743-747

  Newman, Kevin P ^a   Bhattacharya, Syamal K ^a   Munir, Ahmad ^a   Davis, Richard C ^a   Soberman, Judith E ^a   Ramanathan, Kodangudi B ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

African Americans; Calcium; Heart failure; Magnesium; Selenium; Zinc

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; MAGNESIUM; MELANIN; SELENIUM; THIAZIDE DIURETIC AGENT; TRACE ELEMENT; VITAMIN D; ZINC;

AFRICAN AMERICAN; BONE DISEASE; CONGESTIVE HEART FAILURE; DISEASE PREDISPOSITION; HEART EJECTION FRACTION; HUMAN; HYPERALDOSTERONISM; INCIDENCE; NUTRITIONAL DEFICIENCY; OXIDATIVE STRESS; PARENTERAL NUTRITION; PHENOTYPE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SECONDARY HYPERPARATHYROIDISM; SOFT TISSUE DISEASE; VITAMIN D DEFICIENCY; WASTING SYNDROME; WATER RETENTION;

AFRICAN AMERICANS; ALDOSTERONE; HEART FAILURE; HUMANS; NUTRITIONAL STATUS; OXIDATIVE STRESS;

EID: 36148947463     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Abu-Hamdan DK, Desai H, Sondheimer J, et al. 1988. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens, 1(3 Pt 3)303S-8S.
2. Anand IS, Ferrari R, Kalra GS, et al. 1989. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation, 80:299-305.
3. Arroyo M, LaGuardia SP, Bhattacharya SK, et al. 2006. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res, 148:301-8.
4. Bikle DD, Ettinger B, Sidney S, et al. 1999. Differences in calcium metabolism between black and white men and women. Miner Electrolyte Metab, 25:178-84.
5. Chhokar VS, Sun Y, Bhattacharya SK, et al. 2004. Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol, 287:H2023-6.
6. Chhokar VS, Sun Y, Bhattacharya SK, et al. 2005. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation, 111:871-8.
7. Cohanim M, Yendt ER. 1975. The effects of thiazides on serum and urinary zinc in patients with renal calculi. Johns Hopkins Med J, 136:137-41.
8. Francis GS, Benedict C, Johnstone DE, et al. 1990. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation, 82:1724-9.
9. Fuleihan GE, Gundberg CM, Gleason R, et al. 1994. Racial differences in parathyroid hormone dynamics. J Clin Endocrinol Metab, 79:1642-7.
10. Huttunen JK. 1997. Selenium and cardiovascular diseases - an update. Biomed Environ Sci, 10:220-6.
11. Itoh M, Oh-Ishi S, Hatao H, et al. 2004. Effects of dietary calcium restriction and acute exercise on the antioxidant enzyme system and oxidative stress in rat diaphragm. Am J Physiol Regul Integr Comp Physiol, 287: R33-8.
12. Jessup M, Brozena S. 2003. Heart failure. N Engl J Med, 348:2007-18.
13. Khouzam RN, Dishmon DA, Farah V, et al. 2006. Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci, 331:30-4.
14. Kidd P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev, 8:223-46.
15. Koren-Michowitz M, Dishy V, Zaidenstein R, et al. 2005. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study. Am J Hypertens, 18:358-63.
16. LaGuardia SP, Dockery BK, Bhattacharya SK, et al. 2006. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci, 332:112-18.
17. Lee AH, Mull RL, Keenan GF, et al. 1994. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med, 96:35-41.
18. Levy JB, Jones HW, Gordon AC. 1994. Selenium deficiency, reversible cardiomyopathy and short-term intravenous feeding. Postgrad Med J, 70:235-6.
19. Molavi B, Mehta JL. 2004. Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol, 19:488-93.
20. Oster O. 1993. Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin Chim Acta, 214:209-18.
21. Perry HM, 3rd, Miller DY, Morley JE, et al. 1993. A preliminary report of vitamin D and calcium metabolism in older Affican Americans. J Am Geriatr Soc, 41:612-16.
22. Pitt B, Zannad F, Remme WJ, et al. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med, 341:709-17.
23. Quercia RA, Korn S, O'Neill D, et al. 1984. Selenium deficiency and fatal cardiomyopathy in a patient receiving long-term home parenteral nutrition. Clin Pharm, 3:531-5.
24. Ripa S, Ripa R, Giustiniani S. 1998. Are failured cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. Minerva Med, 89:397-403.
25. Shane E, Mancini D, Aaronson K, et al. 1997. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med, 103:197-207.
26. Stefenelli T, Pacher R, Woloszczuk W, et al. 1992. Parathyroid hormone and calcium behavior in advanced congestive heart failure [German]. Z Kardiol, 81:121-5.
27. Stein MS, Scherer SC, Walton SL, et al. 1996. Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol (Oxf), 44:375-83.
28. Swedberg K, Eneroth P, Kjekshus J, et al. 1990. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation, 82:1730-6.
29. Thakur S, Gupta N, Kakkar P. 2004. Serum copper and zinc concentrations and their relation to superoxide dismutase in severe malnutrition. Eur J Pediatr, 163:742-4.
30. The SOLVD Investigators. 1991. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med, 325:293-302.
31. Thomas M, Vidal A, Bhattacharya SY, et al. 2007. Zinc dyshomeostatis in rats with aldosteronism. Response to spironolactone. Am J Physiol Heart Circ Physiol, In press.
32. Ungvari Z, Gupte SA, Recchia FA, et al. 2005. Role of oxidative-nitrosative stress and downstream pathways in various forms of cardiomyopathy and heart failure. Curr Vasc Pharmacol, 3:221-9.
33. Vijaya J, Subramanyam G, Sukhaveni V, et al. 2000. Selenium levels in dilated cardiomyopathy. J Indian Med Assoc, 98:166-9.
34. Villarreal D, Freeman RH, Johnson RA. 1993. Neurohormonal modulators and sodium balance in experimental heart failure. Am J Physiol, 264: H1187-93.
35. Weber KT. 2001. Aldosterone in congestive heart failure. N Engl J Med, 345:1689-97.
36. Wester PO. 1980. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand, 208:209-12.
37. Wykretowicz A, Furmaniuk J, Smielecki J, et al. 2004. The oxygen stress index and levels of circulating interleukin-10 and interleukin-6 in patients with chronic heart failure. Int J Cardiol, 94:283-7.
38. Xia YM, Hill KE, Burk RF. 1989. Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione, peroxidase and other oxidant defense indices in blood. J Nutr, 119:1318-26.
39. Zumkley H, Bertram HP, Vetter H, et al. 1985. Zinc metabolism during captopril treatment. Horm Metab Res, 17:256-8.